151 related articles for article (PubMed ID: 31366502)
1. Electron Microscopic Analysis of Stem Cells in Human Prostate Cancer, Including Inverted Capsule Embedding Methods for Archival Sections and Falcon Films for Prostate Cancer Cell Lines.
Sinha AA
Anticancer Res; 2019 Aug; 39(8):4171-4177. PubMed ID: 31366502
[TBL] [Abstract][Full Text] [Related]
2. Identification of Two Types of Stem Cells in Methylene Blue-stained Sections of Untreated and Diethylstilbestrol-treated Human Prostate Cancer and Their Characterization by Immunogold Localization of CD133.
Sinha AA; Wilson MJ
Anticancer Res; 2018 Oct; 38(10):5725-5732. PubMed ID: 30275193
[TBL] [Abstract][Full Text] [Related]
3. Regulation of the stem cell marker CD133 is independent of promoter hypermethylation in human epithelial differentiation and cancer.
Pellacani D; Packer RJ; Frame FM; Oldridge EE; Berry PA; Labarthe MC; Stower MJ; Simms MS; Collins AT; Maitland NJ
Mol Cancer; 2011 Jul; 10():94. PubMed ID: 21801380
[TBL] [Abstract][Full Text] [Related]
4. Expression analysis of putative stem cell markers in human benign and malignant prostate.
Ugolkov AV; Eisengart LJ; Luan C; Yang XJ
Prostate; 2011 Jan; 71(1):18-25. PubMed ID: 20583131
[TBL] [Abstract][Full Text] [Related]
5. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells.
De Marzo AM; Meeker AK; Epstein JI; Coffey DS
Am J Pathol; 1998 Sep; 153(3):911-9. PubMed ID: 9736039
[TBL] [Abstract][Full Text] [Related]
6. p63 cytoplasmic aberrance is associated with high prostate cancer stem cell expression.
Ferronika P; Triningsih FX; Ghozali A; Moeljono A; Rahmayanti S; Shadrina AN; Naim AE; Wudexi I; Arnurisa AM; Nanwani ST; Harijadi A
Asian Pac J Cancer Prev; 2012; 13(5):1943-8. PubMed ID: 22901151
[TBL] [Abstract][Full Text] [Related]
7. Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.
Miki J; Furusato B; Li H; Gu Y; Takahashi H; Egawa S; Sesterhenn IA; McLeod DG; Srivastava S; Rhim JS
Cancer Res; 2007 Apr; 67(7):3153-61. PubMed ID: 17409422
[TBL] [Abstract][Full Text] [Related]
8. Expression profiling of CD133+ and CD133- epithelial cells from human prostate.
Shepherd CJ; Rizzo S; Ledaki I; Davies M; Brewer D; Attard G; de Bono J; Hudson DL
Prostate; 2008 Jun; 68(9):1007-24. PubMed ID: 18398820
[TBL] [Abstract][Full Text] [Related]
9. Glycoprotein A-80 in the human prostate: immunolocalization in prostatic intraepithelial neoplasia, carcinoma, radiation failure, and after neoadjuvant hormonal therapy.
Coogan CL; Bostwick DG; Bloom KJ; Gould VE
Urology; 2003 Jan; 61(1):248-52. PubMed ID: 12559317
[TBL] [Abstract][Full Text] [Related]
10. Analyzing the Expression of Biomarkers in Prostate Cancer Cell Lines.
Su CY; Huang GC; Chang YC; Chen YJ; Fang HW
In Vivo; 2021; 35(3):1545-1548. PubMed ID: 33910833
[TBL] [Abstract][Full Text] [Related]
11. Acquisition of tumorigenic potential and therapeutic resistance in CD133+ subpopulation of prostate cancer cells exhibiting stem-cell like characteristics.
Kanwal R; Shukla S; Walker E; Gupta S
Cancer Lett; 2018 Aug; 430():25-33. PubMed ID: 29775627
[TBL] [Abstract][Full Text] [Related]
12. The identification of a novel antibody for CD133 using human antibody phage display.
Glumac PM; Forster CL; Zhou H; Murugan P; Gupta S; LeBeau AM
Prostate; 2018 Sep; 78(13):981-991. PubMed ID: 29790189
[TBL] [Abstract][Full Text] [Related]
13. Studies on carcinogenesis of human prostate. III. Long-term explant culture of normal prostate and benign prostatic hyperplasia: transmission and scanning electron microscopy.
Heatfield BM; Sanefuji H; Trump BF
J Natl Cancer Inst; 1982 Oct; 69(4):757-66. PubMed ID: 6181280
[TBL] [Abstract][Full Text] [Related]
14. Microvessel density as a molecular marker for identifying high-grade prostatic intraepithelial neoplasia precursors to prostate cancer.
Sinha AA; Quast BJ; Reddy PK; Lall V; Wilson MJ; Qian J; Bostwick DG
Exp Mol Pathol; 2004 Oct; 77(2):153-9. PubMed ID: 15351240
[TBL] [Abstract][Full Text] [Related]
15. Surface CD24 distinguishes between low differentiated and transit-amplifying cells in the basal layer of human prostate.
Petkova N; Hennenlotter J; Sobiesiak M; Todenhöfer T; Scharpf M; Stenzl A; Bühring HJ; Schwentner C
Prostate; 2013 Oct; 73(14):1576-90. PubMed ID: 23836489
[TBL] [Abstract][Full Text] [Related]
16. Scanning and transmission electron microscopy of human prostatic acinar cells.
Stone MP; Stone KR; Ingram P; Mickey DD; Paulson DF
Urol Res; 1977; 5(4):185-200. PubMed ID: 74116
[TBL] [Abstract][Full Text] [Related]
17. Characterization of benign and malignant prostate epithelial Hoechst 33342 side populations.
Brown MD; Gilmore PE; Hart CA; Samuel JD; Ramani VA; George NJ; Clarke NW
Prostate; 2007 Sep; 67(13):1384-96. PubMed ID: 17639507
[TBL] [Abstract][Full Text] [Related]
18. Isolation, characterization and mobilization of prostate cancer tissue derived CD133+ MDR1+ cells.
Rentala S; Mangamoori LN
J Stem Cells; 2010; 5(2):75-81. PubMed ID: 22049617
[TBL] [Abstract][Full Text] [Related]
19. Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander?
Shah R; Mucci NR; Amin A; Macoska JA; Rubin MA
Am J Pathol; 2001 May; 158(5):1767-73. PubMed ID: 11337374
[TBL] [Abstract][Full Text] [Related]
20. Co-Expression of Putative Cancer Stem Cell Markers CD44 and CD133 in Prostate Carcinomas.
Kalantari E; Asgari M; Nikpanah S; Salarieh N; Asadi Lari MH; Madjd Z
Pathol Oncol Res; 2017 Oct; 23(4):793-802. PubMed ID: 28083789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
